Time for a three-day weekend

The powers that be on Wall Street have deemed April 6 as a market holiday, and who are we to disagree with the wisdom of the markets? We'll be taking off tomorrow for a little R&R. We'll be back on Monday with a full week of biotech coverage. We hope you join us bright and early online. -- John Carroll, Editor (Twitter | LinkedIn)

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.